[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Gérond'if\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":176},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,6,0,[8,42,69,98,126,149],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":25,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100548923","cardiac-amyloidosis-prevalence-of-in-older-subjects-affected-by-heart-failure-100548923",false,"NCT06427304","Cardiac Amyloidosis pRevaleNce of in OLDer Subjects Affected by Heart Failure","ARNOLD","Inclusion Criteria:\n\n* Aged ≥ 80 years\n* Hospitalised for decompensation of heart failure in the last 12 months\n* Subjects with hypertrophy of the septum or left ventricle at cardiac echography (defined as ≥ 12 mm)\n* Subjects able to undergo a bone scintigraphy scan\n* Subjects willing to participate\n\nExclusion Criteria:\n\n* Subjects refusing to participate\n* Subjects admitted to palliative care unit.\n* Subjects under guardianship\n* Subjects with a definite diagnosis of cardiac amyloidosis","ALL","80 Years",{"count":19,"type":20},637,"ESTIMATED","OBSERVATIONAL","Tne aim purpose of this observational, multicentre and propective study is to determine the prevalence of cardiac amyloidosis in geriatric patients aged 80 years and older hospitalized within the last 12 months for heart failure with left ventricular hypertrophy (septum ≥ 12 mm) on echocardiography",[24],"Cardiac Amyloidosis",[26,27,28],"Cardiac amyloidosis","Heart failure with left ventricular hypertrophy","Positive bone scintigraphy","RECRUITING","2026-04-15",{"date":32,"type":33},"2026-04-20","ACTUAL",{"date":35,"type":33},"2024-07-01",{"date":37,"type":20},"2028-02-02",{"name":39,"class":40},"Gérond'if","OTHER",36,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":46,"acronym":47,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":52,"conditions":53,"keywords":55,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":61,"lastUpdatePostDateStruct":62,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":68},"100634393","viral-pulmonary-infections-in-older-age-100634393","NCT07539103","VIRal Pulmonary Infections in Older AGE","VIRAGE","Inclusion Criteria:\n\n* Hospitalized subjects aged ≥ 60 years\n* A respiratory sample collected and tested by polymerase chain reaction (PCR) during hospitalisation as part of standard of care\n\nNote: Reasons for PCR:\n\n1. Patients with Severe acute respiratory infection (SARI)\n2. Patients with symptoms other than SARI\n3. Systematic PCR testing (in the context of clusters or during the winter season) \\* Recent onset of at least one general symptom and at least one functional or physical respiratory sign\n\n   * General symptoms: fever (which may be absent in older patients), chills, sweating, headache, malaise, myalgia, arthralgia, fatigue, decline in general condition (asthenia, weight loss, anorexia, confusion, or dizziness), digestive disturbances.\n   * Respiratory signs: sore throat, rhinorrhoea (common cold), cough, wheezing, dyspnoea, chest pain, or recent auscultatory abnormalities (diffuse or focal).\n   * Subjects willing to participate, with a non-opposition form completed and signed by the qualified and trained healthcare professional responsible for providing the participant information\n   * Subject affiliated to a health insurance system\n\nExclusion Criteria:\n\n* Subjects refusing to participate\n* Subjects admitted to palliative care unit.\n\n  * Subjects under guardianship\n  * Any condition that, in the opinion of the investigator, may interfere with the aim of the study or wellbeing of the patient","60 Years",{"count":51,"type":20},5900,"Severe acute respiratory infections (SARIs) represent one of the leading causes of hospitalization and mortality worldwide. These infections are associated with substantial in-hospital mortality and often constitute a turning point in the medium-term prognosis of older patients and those with comorbid conditions.\n\nSARIs are most frequently of viral origin, involving well-known pathogens such as Orthomyxoviridae (influenza A and B viruses), Pneumoviridae \\[(respiratory syncytial virus (RSV), human metapneumovirus (hMPV)\\], Paramyxoviridae \\[parainfluenza viruses (PIV)\\], adenoviruses, or rhinoviruses, as well as emerging viruses such as pandemic influenza strains and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic.\n\nAge-related immune decline (immunosenescence) increases the risk of severe forms and related respiratory or cardiovascular complications. However, the prevalence and burden of the different viral etiologies of Severe acute respiratory infections (SARIs) in older adults remain limited and insufficiently characterized.\n\nThe primary objective is to determine the proportion of viral respiratory infections attributable to polymerase chain reaction (PCR)-confirmed pathogen agents among hospitalized older subjects (≥60 years old).",[54],"Viral Pulmonary Infections",[56,57,58,59],"PCR","viral respiratory infections","viral respiratory pathogen","polymerase chain reaction","NOT_YET_RECRUITING","2026-04-13",{"date":32,"type":33},{"date":64,"type":20},"2026-06-01",{"date":66,"type":20},"2028-09-30",{"name":39,"class":40},20,{"id":70,"slug":71,"hasResults":11,"nctId":72,"briefTitle":73,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":11,"sex":16,"minAge":49,"maxAge":4,"enrollmentInfo":76,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":78,"conditions":79,"keywords":83,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":92,"completionDateStruct":94,"leadSponsor":96,"locationsCount":97},"100568163","evaluation-of-medical-and-social-care-for-elderly-patients-between-hospital-and-home-temporary-accommodation-out-of-hospitalization-by-nursing-home-and-long-term-care-units-in-ile-de-france-region-100568163","NCT06677645","Evaluation of Medical and Social Care for Elderly Patients, Between Hospital and Home: TEMPORARY ACCOMMODATION Out of Hospitalization by Nursing Home and Long-Term Care Units in Ile-de-France Region","HTSH","* Inclusion Criteria:\n\n  1. Patient selection criteria\n\n     * Patient male or female at least 60 years of age, as initially defined with the Regional Health Agency, discharged from hospital,\n     * Oral expression of non opposition to participation in the study, documented in the medical record by the physician,\n     * Presenting a defined and feasible plan for returning home,\n     * Whose social\u002Fmedical situation (stabilized) does not allow an immediate return home after hospitalization.\n  2. Caregiver selection criteria\n\n     * Person with an unpaid caregiving activity for their relative in HTSH,\n     * Person verbally expressing their non-opposition to participating in the study, and documented in the medical record of the patient they are helping,\n     * A person who is able to understand the study questionnaires and evaluations, and is able to answer them without the help of a third party.\n  3. Professional selection criteria\n\n     * Salaried professional, nursing or not, regularly and directly involved in the HTSH circuit, whether in hospital or in nursing home \u002F long term care units, for at least 6 months,\n     * Oral expression of non opposition to participation in the study, documented by the establishment.\n* Non-inclusion Criteria:\n\n  * Be already included in another clinical study,\n  * Benefit from a legal protection measure or be unable to express their consent, in accordance with article L1121-8 of the French Public Health Code.",{"count":77,"type":20},258,"Prospective, observational, non-interventional, comparative, multicenter RIPH3 study to investigate the impact of HTSH on length of hospital stay in referring services.",[80,81,82],"Social Care","Medical Care","Elderly Patients",[84,85,86,87,88],"social care","Tempory hospitalization","Elderly people","Medical care","medical-economic study","2025-06-10",{"date":91,"type":33},"2025-06-13",{"date":93,"type":33},"2024-11-20",{"date":95,"type":20},"2027-11-20",{"name":39,"class":40},10,{"id":99,"slug":100,"hasResults":11,"nctId":101,"briefTitle":102,"officialTitle":102,"acronym":103,"eligibilityCriteria":104,"healthyVolunteers":11,"sex":16,"minAge":105,"maxAge":4,"enrollmentInfo":106,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":108,"conditions":109,"keywords":111,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":117,"lastUpdatePostDateStruct":118,"startDateStruct":120,"completionDateStruct":122,"leadSponsor":124,"locationsCount":125},"100363486","determinant-of-the-risk-of-the-becoming-frail-in-the-non-dependent-elederly-100363486","NCT04012840","Determinant of the Risk of the Becoming Frail in the Non-dependent Elederly","DEPART","Inclusion criteria :\n\n* Age ≥ 70 years old\n* Patient with frailty risks according to a survey recommended by HAS (Gérontopôle of Toulouse)\n* ADL≥5\n* Agreeing to take part in a geriatric assessment in a prevention center or in a Day hospital in Île-de-France\n* Agreeing to be followed by phone every 6 months for 3 years\n* Eligible to a social security system\n\nExclusion criteria :\n\n* A stated loss of autonomy\n* Individual under guardianship, curatorship, judicial supervision","70 Years",{"count":107,"type":20},2000,"As an active and healthy ageing, \"Successful Ageing\" is a societal challenge for all countries members according to the European Commission. This study is intended to contribute to increase healthy, active and non-dependent lifetime. To this end the main goal is to highlight clinical and biological frailty determinants in elderly with potential weaknesses.",[110],"Risk of Frailty in Elderly",[112,113,114,115,116],"Frailty","Fried's criteria","Rockwood's criteria","Loss of autonomy,","elderly","2025-04-11",{"date":119,"type":33},"2025-04-16",{"date":121,"type":33},"2018-06-26",{"date":123,"type":20},"2030-12-25",{"name":39,"class":40},1,{"id":127,"slug":128,"hasResults":11,"nctId":129,"briefTitle":130,"officialTitle":130,"acronym":131,"eligibilityCriteria":132,"healthyVolunteers":11,"sex":16,"minAge":133,"maxAge":4,"enrollmentInfo":134,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":136,"conditions":137,"keywords":139,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":141,"lastUpdatePostDateStruct":142,"startDateStruct":144,"completionDateStruct":146,"leadSponsor":148,"locationsCount":125},"100550547","evaluation-of-the-new-peri-operative-geriatric-units-in-ile-de-france-in-digestive-and-urological-surgery-100550547","NCT06448494","Evaluation of the New Peri-Operative Geriatric Units in Ile-de-France, in Digestive and Urological Surgery","UPOG-DIGU","Inclusion Criteria:\n\n* Male or female subject, aged ≥ 75 years,\n* Subject receiving or having received one of the 9 procedures targeted by the study: colectomy, or cholecystectomy, or nephrectomy, or transurethral resection of prostate adenoma, or transurethral prostatectomy, or transurethral or transcutaneous surgery for non-lithiasis conditions, or kidney and ureter surgery and major bladder surgery for tumor disease, or esophageal, stomach and duodenal surgery for malignancy, or transurethral resection of bladder,\n* Subject orally agreeing (non-opposition), after having been informed and having been given a reasonable period of reflection, to participate in the study.\n\nExclusion Criteria:\n\n* Patient having to undergo, at the time the study is proposed and over the theoretical period of participation, one or more other interventions already scheduled (other than the 9 mentioned in the inclusion criteria), and which, in the investigator's opinion, could have an impact on the study indicators7\n* Subject unable to understand the purpose of the research, to answer questions and to give his\u002Fher decision to participate in the study,\n* Subjects under legal protection or unable to express their consent, in accordance with article L1121-8 of the French Public Health Code,\n* Subject already included in another research project involving the human body,\n* Subject not affiliated to or not benefiting from a social security scheme.","75 Years",{"count":135,"type":20},1400,"The main objective of this study is to evaluate the effectiveness of experimental management by digestive or urological \"new Peri-Operative Geriatric Units\", on post-operative follow-up in the 3 months following the procedure.\n\nMedical follow-up in the 10 days following the operation up to discharge, and patient outcomes in the 3 months following the operation, will be documented.\n\nThese data will be compared with data from subjects operated on in the reference year.",[138],"Digestive and Urological Surgery",[138,140],"Peri-operative geriatric unit","2024-06-04",{"date":143,"type":33},"2024-06-07",{"date":145,"type":33},"2023-05-31",{"date":147,"type":20},"2025-08-28",{"name":39,"class":40},{"id":150,"slug":151,"hasResults":11,"nctId":152,"briefTitle":153,"officialTitle":154,"acronym":155,"eligibilityCriteria":156,"healthyVolunteers":11,"sex":16,"minAge":133,"maxAge":4,"enrollmentInfo":157,"targetDuration":159,"studyType":21,"phases":4,"briefSummary":160,"conditions":161,"keywords":164,"overallStatus":60,"whyStopped":4,"lastUpdateSubmitDate":168,"lastUpdatePostDateStruct":169,"startDateStruct":171,"completionDateStruct":173,"leadSponsor":175,"locationsCount":4},"100545131","clinical-and-therapeutic-characteristics-of-geriatric-patients-hospitalized-for-heart-failure-aging-hf-study-age-and-heart-failure-in-geriatrics-100545131","NCT06377904","Clinical and Therapeutic Characteristics of Geriatric Patients Hospitalized for Heart Failure (AGING HF Study (AGe and Heart Failure IN Geriatrics))","Clinical and Therapeutic Characteristics of Geriatric Patients Hospitalized for Heart Failure","AGING HF","Inclusion Criteria:\n\n* Patients aged 75 and over Hospitalized in a geriatric ward with heart failure No oral opposition from patient\n\nExclusion Criteria:\n\n* Patient under 75 years of age Patient not wishing to participate in the study Subject under guardianship\u002Fcuratorship\u002Fsupervision of justice",{"count":158,"type":20},810,"1 Year","This retrospective (between April 2020 and December 2023) then prospective (between January 2024 and August 2026), non-interventional cohort study has as its main objective to evaluate the clinical and therapeutic characteristics of patients aged 75 and over hospitalized in geriatrics for heart failure and also to evaluate the clinical characteristics and triggering factor(s) of acute heart failure.",[162,163],"Patients Hospitalized in Geriatrics for Heart Failure","Patients Aged 75 and Over",[165,166,167],"Heart failure","Geriatrics","AGE","2024-04-17",{"date":170,"type":33},"2024-04-22",{"date":172,"type":20},"2024-04",{"date":174,"type":20},"2028-04",{"name":39,"class":40},""]